Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
Tremblay S, Alhogbani M, Weickhardt A, Davis ID, Scott AM, Hicks RJ, Metser U, Chua S, Davda R, Punwani S, Payne H, Tunariu N, Ho B, Young S, Singbo MNU, Bauman G, Emmett L, Pouliot F. Tremblay S, et al. Among authors: davda r. Cancer Imaging. 2023 Jun 8;23(1):57. doi: 10.1186/s40644-023-00570-x. Cancer Imaging. 2023. PMID: 37291656 Free PMC article.
Hormone therapy for radiorecurrent prostate cancer.
Payne H, Khan A, Chowdhury S, Davda R. Payne H, et al. Among authors: davda r. World J Urol. 2013 Dec;31(6):1333-8. doi: 10.1007/s00345-012-0952-8. Epub 2012 Sep 21. World J Urol. 2013. PMID: 22996761 Review.
Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.
Adeleke S, Latifoltojar A, Sidhu H, Galazi M, Shah TT, Clemente J, Davda R, Payne HA, Chouhan MD, Lioumi M, Chua S, Freeman A, Rodriguez-Justo M, Coolen A, Vadgama S, Morris S, Cook GJ, Bomanji J, Arya M, Chowdhury S, Wan S, Haroon A, Ng T, Ahmed HU, Punwani S. Adeleke S, et al. Among authors: davda r. BMC Med Imaging. 2019 Nov 15;19(1):90. doi: 10.1186/s12880-019-0380-y. BMC Med Imaging. 2019. PMID: 31730466 Free PMC article. Clinical Trial.
Toxicity Outcomes in the Elderly Prostate Cancer Patient.
Prentice M, Davda R, Nuhoglu Savas A, Payne H. Prentice M, et al. Among authors: davda r. Clin Oncol (R Coll Radiol). 2018 Jan;30(1):e37. doi: 10.1016/j.clon.2017.10.018. Epub 2017 Nov 20. Clin Oncol (R Coll Radiol). 2018. PMID: 29157797 No abstract available.
Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
Nathan A, Ng A, Mitra A, Sooriakumaran P, Davda R, Patel S, Fricker M, Kelly J, Shaw G, Rajan P, Sridhar A, Nathan S, Payne H. Nathan A, et al. Among authors: davda r. Clin Oncol (R Coll Radiol). 2022 Jan;34(1):e69-e78. doi: 10.1016/j.clon.2021.10.012. Epub 2021 Nov 3. Clin Oncol (R Coll Radiol). 2022. PMID: 34740477
Advances in advanced prostate cancer - the continuing journey.
Payne H, Davda R, Jones R, Crabb S, Troup J, Hughes S. Payne H, et al. Among authors: davda r. BJU Int. 2016 Jul;118(1):17-9. doi: 10.1111/bju.13350. Epub 2015 Nov 4. BJU Int. 2016. PMID: 26456636 No abstract available.
A Phase II, Open-label study to assess safety and management change using 68Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study.
Afaq A, Payne H, Davda R, Hines J, Cook GJR, Meagher M, Priftakis D, Warbey VS, Kelkar A, Orczyk C, Mitra A, Needleman S, Ferris M, Mullen G, Bomanji J. Afaq A, et al. Among authors: davda r. J Nucl Med. 2021 Mar 19;62(12):1727-34. doi: 10.2967/jnumed.120.257527. Online ahead of print. J Nucl Med. 2021. PMID: 33741648 Free PMC article.
Chemotherapy at First Diagnosis of Advanced Prostate Cancer - Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer.
Davda R, Hughes S, Jones R, Crabb SJ, Troup J, Payne H. Davda R, et al. Clin Oncol (R Coll Radiol). 2016 Jun;28(6):376-85. doi: 10.1016/j.clon.2016.01.006. Epub 2016 Feb 11. Clin Oncol (R Coll Radiol). 2016. PMID: 26874654 Free article. Afrikaans, English.
35 results